All In Biotech

Drug Trial Radar · NCT02870205

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)

A Double-Blind, Randomized, Parallel-Group Seasonal Allergic Rhinitis (SAR) Study to Evaluate the Efficacy, Safety and Tolerability of GSP 301 Nasal Spray Compared With Placebo Nasal Spray and Individual Monotherapy Formulations (Olopatadine Hydrochloride Nasal Spray and Mometasone Furoate Nasal Spray) in Adult and Adolescent Subjects (12 Years of Age and Older)

Last checked: Nov 19, 2026Latest source record: Apr 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,176 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,176

Actual

Start

Aug 2016

Primary completion

Jan 2017

Study completion Jan 2017

Sponsor

Lead sponsor
Glenmark Specialty S.A.Industry
Sponsor type
Industry
First posted
Aug 17, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study to evaluate the efficacy, safety and tolerability of GSP 301 NS compared with placebo NS and individual monotherapy formulations for the treatment of Seasonal Allergic Rhinitis (subjects 12 years of age and older)

Conditions

  • Seasonal Allergic Rhinitis (SAR)

Interventions

  • GSP 301 NSDrug

    2 spray in each nostril twice daily for 14 days

  • GOM-NSDrug

    2 spray in each nostril twice daily for 14 days

  • GMM-2 NSDrug

    2 spray in each nostril twice daily for 14 days

  • GSP 301 placebo NSDrug

    2 spray in each nostril twice daily for 14 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Average AM and PM Subject-reported 12-hour Reflective Total Nasal Symptom Score (rTNSS)Time frame: Baseline and day 14

Locations

43 sites in 1 country. Site status is shown where the registry gives one.

  • Investigational Site 406

    Mission Viejo, California

  • Investigational Site 414

    Orange, California

  • Investigational Site 435

    San Diego, California

  • Investigational Site 420

    Centennial, Colorado

  • Investigational Site 444

    Colorado Springs, Colorado

  • Investigational Site 428

    Aventura, Florida

  • Investigational Site 412

    Miami, Florida

  • Investigational Site 436

    Bethesda, Maryland

  • Investigational Site 432

    South Dartmouth, Massachusetts

  • Investigational Site 426

    Minneapolis, Minnesota

  • Investigational Site 403

    Plymouth, Minnesota

  • Investigational Site 443

    Columbia, Missouri

  • Investigational Site 441

    Rolla, Missouri

  • Investigational Site 440

    St Louis, Missouri

  • Investigational Site 405

    Bellevue, Nebraska

  • Investigational Site 434

    Skillman, New Jersey

  • Investigational Site 408

    Rochester, New York

  • Investigational Site 418

    Rockville Centre, New York

  • Investigational Site 402

    High Point, North Carolina

  • Investigational Site 427

    Raleigh, North Carolina

  • Investigational Site 419

    Cincinnati, Ohio

  • United States 404

    Cincinnati, Ohio

  • United States 407

    Edmond, Oklahoma

  • Investigational Site 410

    Oklahoma City, Oklahoma

  • Investigational Site 424

    Tulsa, Oklahoma

  • Investigational Site 411

    Pittsburgh, Pennsylvania

  • Investigational Site 416

    Spartanburg, South Carolina

  • Investigational Site 415

    Austin, Texas

  • Investigational Site 442

    Austin, Texas

  • Investigational Site 417

    Boerne, Texas

  • Investigational Site 421

    Dallas, Texas

  • Investigational Site 430

    Dallas, Texas

  • Investigational Site 431

    El Paso, Texas

  • Investigational Site 433

    Kerrville, Texas

  • Investigational Site 422

    New Braunfels, Texas

  • Investigational Site 401

    San Antonio, Texas

  • Investigational Site 413

    San Antonio, Texas

  • Investigational Site 425

    San Antonio, Texas

  • Investigational Site 437

    San Antonio, Texas

  • Investigational Site 400

    Waco, Texas

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.